Federal Supply Schedule 36F79724D059E

Award Date 9/15/24
Last Date to Order 3/14/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Ars Pharmaceuticals Operations, Inc. The contract has a period of performance from March 15, 2025 to March 14, 2030 and a ceiling value of $225,000.00. The contract is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products under Federal Supply Schedule 65 IB. No specific task orders or price lists were provided, but the contract aims to...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract, valued at a ceiling of $300,000.00, was awarded to Yaral Pharma Inc., a for-profit manufacturer, for a period of performance ending on April 30, 2028. The contract falls under Schedule 65 I B, "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS", and is intended to provide the agency...
The Federal Supply Schedule (FSS) contract 36F79724D037E was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Day One Biopharmaceuticals, Inc. on June 3, 2024. The contract is a multiple award under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products, with a ceiling value of $25,000.00 and a period of performance through November 30, 2024. The purpose of this FSS contract is to provide the VISN 12 agency with interim...
The Federal Supply Schedule (FSS) contract award 36F79724D0047 was issued by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,188,000.00 and a period of performance through December 31, 2028. The contract was awarded to Nnodum Pharmaceuticals Corp, a minority-owned and SBA-certified 8(a) small disadvantaged business. The contract is for the procurement of 65 I B, DRUGS,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government, to Aurobindo Pharma USA Inc., a foreign-owned for-profit organization. The contract was awarded on March 15, 2020, with a ceiling value of $700,000.00 and a period of performance ending on March 14, 2026. The contract scope covers the procurement of drugs, pharmaceuticals, and hematology-related products under the General Services...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Acertis Pharmaceuticals LLC, a for-profit limited liability company that manufactures goods. The $25,000.00 contract is an interim agreement under FSS Schedule 65 I B, which covers drugs, pharmaceuticals, and hematology-related products. It has a period of performance ending on September 28, 2023. The contract does not use any set-asides and is a multiple...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract was awarded to Haleon US LP, a for-profit manufacturer, with a ceiling value of $9,867,650.00 and a period of performance through September 30, 2026. The FSS contract, categorized under Schedule 65 IB, aims to provide the VA's VISN 12 with a wide...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract has a ceiling value of $1,980,000.00 and a period of performance that runs through January 1, 2026. The contracted products and services under this multiple award FSS-61-IB schedule include drugs, pharmaceuticals, and hematology-related products. The prime contractor, Llorens Pharmaceutical International...
  • 36F79724D059E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Ars Pharmaceutical Operations, Inc. The $1,025,000.00 contract is for the delivery of drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 I B. The contract has a period of performance from September 15, 2024 to March 14, 2025 and was set up as a multiple award vehicle with no set-asides. As an FSS contract, the awarded prime contractor will provide products and services through the established FSS program, which allows federal agencies to streamline their procurement of commercial items. The scope and purpose of the contract is to provide the VISN 12 agency with the necessary pharmaceutical and hematology-related products to support its healthcare operations and requirements.

Generated 2/21/25, 9:18 AM